BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 33242496)

  • 1. X-aptamers targeting Thy-1 membrane glycoprotein in pancreatic ductal adenocarcinoma.
    Wang H; Li X; Lai LA; Brentnall TA; Dawson DW; Kelly KA; Chen R; Pan S
    Biochimie; 2021 Feb; 181():25-33. PubMed ID: 33242496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-Specific Delivery of 5-Fluorouracil-Incorporated Epidermal Growth Factor Receptor-Targeted Aptamers as an Efficient Treatment in Pancreatic Ductal Adenocarcinoma Models.
    Mahajan UM; Li Q; Alnatsha A; Maas J; Orth M; Maier SH; Peterhansl J; Regel I; Sendler M; Wagh PR; Mishra N; Xue Y; Allawadhi P; Beyer G; Kühn JP; Marshall T; Appel B; Lämmerhirt F; Belka C; Müller S; Weiss FU; Lauber K; Lerch MM; Mayerle J
    Gastroenterology; 2021 Sep; 161(3):996-1010.e1. PubMed ID: 34097885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thy1-Targeted Microbubbles for Ultrasound Molecular Imaging of Pancreatic Ductal Adenocarcinoma.
    Abou-Elkacem L; Wang H; Chowdhury SM; Kimura RH; Bachawal SV; Gambhir SS; Tian L; Willmann JK
    Clin Cancer Res; 2018 Apr; 24(7):1574-1585. PubMed ID: 29301827
    [No Abstract]   [Full Text] [Related]  

  • 4. Detection of pancreatic ductal adenocarcinoma in mice by ultrasound imaging of thymocyte differentiation antigen 1.
    Foygel K; Wang H; Machtaler S; Lutz AM; Chen R; Pysz M; Lowe AW; Tian L; Carrigan T; Brentnall TA; Willmann JK
    Gastroenterology; 2013 Oct; 145(4):885-894.e3. PubMed ID: 23791701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toward the Clinical Development and Validation of a Thy1-Targeted Ultrasound Contrast Agent for the Early Detection of Pancreatic Ductal Adenocarcinoma.
    Bam R; Daryaei I; Abou-Elkacem L; Vilches-Moure JG; Meuillet EJ; Lutz A; Marinelli ER; Unger EC; Gambhir SS; Paulmurugan R
    Invest Radiol; 2020 Nov; 55(11):711-721. PubMed ID: 32569010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a panel of DNA Aptamers with High Affinity for Pancreatic Ductal Adenocarcinoma.
    Champanhac C; Teng IT; Cansiz S; Zhang L; Wu X; Zhoa Z; Fu T; Tan W
    Sci Rep; 2015 Nov; 5():16788. PubMed ID: 26603187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection of PD1/PD-L1 X-Aptamers.
    Wang H; Lam CH; Li X; West DL; Yang X
    Biochimie; 2018 Feb; 145():125-130. PubMed ID: 28912094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aptamers: a novel targeted theranostic platform for pancreatic ductal adenocarcinoma.
    Li Q; Maier SH; Li P; Peterhansl J; Belka C; Mayerle J; Mahajan UM
    Radiat Oncol; 2020 Aug; 15(1):189. PubMed ID: 32758252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Cholecystokinin B Receptor-Specific DNA Aptamer for Targeting Pancreatic Ductal Adenocarcinoma.
    Clawson GA; Abraham T; Pan W; Tang X; Linton SS; McGovern CO; Loc WS; Smith JP; Butler PJ; Kester M; Adair JH; Matters GL
    Nucleic Acid Ther; 2017 Feb; 27(1):23-35. PubMed ID: 27754762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD90 highly expressed population harbors a stemness signature and creates an immunosuppressive niche in pancreatic cancer.
    Shi J; Lu P; Shen W; He R; Yang MW; Fang Y; Sun YW; Niu N; Xue J
    Cancer Lett; 2019 Jul; 453():158-169. PubMed ID: 30954649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RACK1 overexpression associates with pancreatic ductal adenocarcinoma growth and poor prognosis.
    Li X; Xiao Y; Fan S; Xiao M; Wang X; Chen X; Li C; Zong G; Zhou G; Wan C
    Exp Mol Pathol; 2016 Oct; 101(2):176-186. PubMed ID: 27498047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted Delivery of C/EBPα -saRNA by Pancreatic Ductal Adenocarcinoma-specific RNA Aptamers Inhibits Tumor Growth In Vivo.
    Yoon S; Huang KW; Reebye V; Mintz P; Tien YW; Lai HS; Sætrom P; Reccia I; Swiderski P; Armstrong B; Jozwiak A; Spalding D; Jiao L; Habib N; Rossi JJ
    Mol Ther; 2016 Jun; 24(6):1106-1116. PubMed ID: 26983359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of CD90 (Thy-1) in pancreatic adenocarcinoma present in the tumor microenvironment.
    Zhu J; Thakolwiboon S; Liu X; Zhang M; Lubman DM
    PLoS One; 2014; 9(12):e115507. PubMed ID: 25536077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multivariate data analysis for the detection of human alpha-acid glycoprotein aberrant glycosylation in pancreatic ductal adenocarcinoma.
    Mancera-Arteu M; Giménez E; Balmaña M; Barrabés S; Albiol-Quer M; Fort E; Peracaula R; Sanz-Nebot V
    J Proteomics; 2019 Mar; 195():76-87. PubMed ID: 30641231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA Aptamer Selected against Pancreatic Ductal Adenocarcinoma for in vivo Imaging and Clinical Tissue Recognition.
    Wu X; Zhao Z; Bai H; Fu T; Yang C; Hu X; Liu Q; Champanhac C; Teng IT; Ye M; Tan W
    Theranostics; 2015; 5(9):985-94. PubMed ID: 26155314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficient screening for 8-oxoguanine DNA glycosylase binding aptamers via capillary electrophoresis].
    Han S; Zhao L; Yang G; Qu F
    Se Pu; 2021 Jul; 39(7):721-729. PubMed ID: 34227370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin 35 Expression Correlates With Microvessel Density in Pancreatic Ductal Adenocarcinoma, Recruits Monocytes, and Promotes Growth and Angiogenesis of Xenograft Tumors in Mice.
    Huang C; Li Z; Li N; Li Y; Chang A; Zhao T; Wang X; Wang H; Gao S; Yang S; Hao J; Ren H
    Gastroenterology; 2018 Feb; 154(3):675-688. PubMed ID: 28989066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carcinoembryonic antigen as a specific glycoprotein ligand of rBC2LCN lectin on pancreatic ductal adenocarcinoma cells.
    Furuta T; Oda T; Kiyoi K; Yusuke O; Kimura S; Kurimori K; Miyazaki Y; Yu Y; Furuya K; Akashi Y; Shimomura O; Tateno H
    Cancer Sci; 2021 Sep; 112(9):3722-3731. PubMed ID: 34115906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melatonin overcomes gemcitabine resistance in pancreatic ductal adenocarcinoma by abrogating nuclear factor-κB activation.
    Ju HQ; Li H; Tian T; Lu YX; Bai L; Chen LZ; Sheng H; Mo HY; Zeng JB; Deng W; Chiao PJ; Xu RH
    J Pineal Res; 2016 Jan; 60(1):27-38. PubMed ID: 26445000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening of Focused Compound Library Targeting Liver X Receptors in Pancreatic Cancer Identified Ligands with Inverse Agonist and Degrader Activity.
    Karaboga H; Huang W; Srivastava S; Widmann S; Addanki S; Gamage KT; Mazhar Z; Ebalunode JO; Briggs JM; Gustafsson JÅ; Filgueira CS; Gilbertson SR; Lin CY
    ACS Chem Biol; 2020 Nov; 15(11):2916-2928. PubMed ID: 33074669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.